Compositions and methods for the treatment of tumor of hematopoietic origin

Details for Australian Patent Application No. 2009210627 (hide)

Owner GENENTECH, INC.

Inventors Elkins, Kristi; Crowley, Craig; Eaton, Dan L.; Ross, Sarajane; Smith, Victoria; Ebens Jr., Allen; Polson, Andrew; Vandlen, Richard L.; Desauvage, Frederic J.; Hongo, Jo-Anne S.; Zheng, Bing; Junutula, Jagath Reddy

Agent Griffith Hack

Pub. Number AU-A-2009210627

PCT Pub. Number WO2009/099719

Priority 12/023,811 31.01.08 US

Filing date 13 January 2009

Wipo publication date 13 August 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/099719 Priority application(s): WO2009/099719

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009210631-Winding cores for material rolls having high roll strain energy, and method for making same

2009210624-Novel vaccines against multiple subtypes of dengue virus